|
Biotech
> Cancer Prevention Pharmaceuticals appointed Jon Saxe to its board of directors. Release
> STAAR Surgical Company ($STAA) named Dr. Jon Hayashida as vice president of global clinical and medical affairs. Release
> Matinas BioPharma appointed David Perlin to its scientific advisory board. Release
> Novogen ($NVGN) named Iain Ross as acting CEO and reappointed him to the board of directors. Release
> Alcresta appointed Dr. Russell Clayton as chief medical officer. Release
> Christopher LeMasters joins Promosome as CEO. Release
> Inotek Pharma ($ITEK) appointed Dr. Cadmus Collins Rich as vice president of medical affairs and clinical development. Release
> Ignyta ($RXDX) named Bernard Parker as chief commercial officer. Release
> Dr. Carl Bjartmar joins Wilson Therapeutics as chief medical officer. Release
> Voyager Therapeutics appointed Michael Higgins to its board of directors. Release
> Proteon Therapeutics ($PRTO) added Scott Canute to its board of directors. Release
> BioQuiddity appointed Daniel Tasse to its board of directors. Release
> Dr. Timothy Franson joins Paratek Pharma's board of directors. Release
> Intercept Pharma ($ICPT) named Richard Kim as senior vice president, commercial head of U.S. Release
> Izun Pharma appointed Jack Talley as CEO. Release
> Tonix Pharma ($TNPX) appointed Mark Edgar as senior vice president of product development. Release
> Zosano Pharma ($ZSAN) hired Donald Kellerman as vice president of clinical development, David Zhang as executive director of biostatistics and data management and Jacquie Mardell as senior director of clinical operations. Release (PDF)
> FORMA Therapeutics appointed Dr. John Hohneker, formerly of Novartis ($NVS), as executive vice president and head of research and development. Release
> RaNA Therapeutics added Dr. Joshua Resnick to its board of directors. Release
> RRD International hired Dr. Ulrich Thienel as its chief development and medical officer. Release
> Trevena appointed Yacoub Habib as its senior vice president of business development and corporate planning. Release
> Etubics named Dr. Thomas Caskey to its board of directors and Drs. Jerome Zeldis and Slobodan Paessler to its scientific advisory board. Release
> Applied Proteomics appointed Robert Verfurth as its vice president of sales. Release
> Inotek Pharmaceuticals ($ITEK) appointed Claudine Prowse as its vice president of strategy and its investor relations officer. Release
> Oxigene ($OXGN) brought on Matthew Loar as its chief financial officer. Release
> Julian Gangolli joined GW Pharma's board of directors. Release
> Hanger hired Scott Ranson as its new chief information officer. Release
> David Berman joined MedImmune as its head of oncology. Release
Pharma
> The Generic Pharmaceutical Association named Chester Davis Jr. as its president and CEO to replace the outgoing Ralph Neas. Release
Med Tech
> Avery Biomedical Devices appointed Neil Grossman as director of sales. Release
> Titan Spine appointed Jim Sevey as the company's senior nanotechnology specialist. Release
> Toshiba America Medical Systems named Satrajit Misra as vice president of marketing. Release
> HeartFlow hired Phil Mui to its product and engineering team. Release
> iRhythm Technologies appointed Marga Ortigas-Wedekind as its executive vice president of global marketing. Release
Biotech IT
> GenoSpace expanded its business advisory board, adding Brian Schmidt, Rebecca Kaiser and Thomas Naughton. Release
Diagnostics
> Dr. Geoffrey Ginsburg joins Alere's ($ALR) board of directors. Release
> Illumina ($ILMN) named Sanjay Chikarmane its senior vice president and general manager of enterprise informatics. Release
Animal Health
> Henry Schein promoted Peter McCarthy to the role of president of its global animal health group. Release
|
